Laser Vision Centers, Inc. (NASDAQ: LVCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: W Shakespeare who wrote (172)	9/27/1998 9:20:00 PM
From: DRL	Read Replies (1) of 413

Summary from report... 09/25/98 Laser Vision Centers (LVCI $11.38,2-S,Tgt $14.00) Geoffrey E. Harri --SUMMARY:--Laser Vision Centers, Inc.--Healthcare Products/Services * We are initiating coverage of LVCI with a 2S rating and a $14 price target. LVCI provides access to excimer lasers. Excimer lasers are used by eye doctors to treat refractive eye disorders. * Our CY98 and CY99 projections are $0.15 and $0.51, respectively; we are assuming the company grows EPS, on a normalized basis, at a rate of 30% per year. * The excimer laser industry is growing significantly - in 1997, 200,000 procedures were performed; it is estimated that by the year 2000, 700,000 procedures/year will be performed. * LVCI, by (i) bringing the excimer laser directly to the doctors' offices and (ii) targeting smaller cities, is the first publicly traded excimer laser access company to report a profit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next